pyruvaldehyde has been researched along with alpha-synuclein in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, KY; Lee, D; Paik, SR; Park, CW | 1 |
| Dai, R; Deng, Y; Ding, W; Lin, F; Peng, L; Qing, H; Ullah, K; Xie, B | 1 |
| Asiago, JM; Aslam, K; Drendel, HM; Goode, KM; Hazbun, TR; Paul, LN; Rochet, JC; Tsai, CJ | 1 |
| Breda, C; Cordeiro, C; Darendelioglu, E; de Oliveira, RM; Engelender, S; Enguita, FJ; Ferreira, DG; Giorgini, F; Gomes, MA; Heinrich, M; Jovin, TM; Klucken, J; Lashuel, HA; Lopes, LV; Martins, IC; Munari, F; Oliveira, LMA; Oliveira, M; Outeiro, TF; Penque, D; Ponces-Freire, A; Quintas, A; Riess, O; Rodrigues, EF; Rott, R; Santos, NC; Simões, T; Szego, ÉM; Vicente Miranda, H; Xiang, W; Zamolo, I; Zweckstetter, M | 1 |
| König, A; Outeiro, TF; Vicente Miranda, H | 1 |
| Kalivendi, SV; Rao, SP; Sharma, N | 1 |
| Chegão, A; Enguita, FJ; Fernandes Gomes, B; Oliveira, MS; Outeiro, TF; Vicente Miranda, H | 1 |
| Buell, AK; Dominguez-Meijide, A; Farzadfard, A; König, A; Nielsen, J; Otzen, DE; Outeiro, TF; Petersen, SV; Vasili, E | 1 |
1 review(s) available for pyruvaldehyde and alpha-synuclein
| Article | Year |
|---|---|
Alpha-Synuclein Glycation and the Action of Anti-Diabetic Agents in Parkinson's Disease.
Topics: alpha-Synuclein; Diabetes Complications; Glucose; Glycation End Products, Advanced; Glycosylation; Homeostasis; Humans; Hypoglycemic Agents; Maillard Reaction; Parkinson Disease; Protein Processing, Post-Translational; Pyruvaldehyde; Risk Factors | 2018 |
7 other study(ies) available for pyruvaldehyde and alpha-synuclein
| Article | Year |
|---|---|
The modification of alpha-synuclein by dicarbonyl compounds inhibits its fibril-forming process.
Topics: alpha-Synuclein; Cell Line, Tumor; Circular Dichroism; Glycation End Products, Advanced; Glyoxal; HeLa Cells; Humans; Liposomes; Oxidation-Reduction; Protein Conformation; Protein Structure, Quaternary; Pyruvaldehyde; Temperature | 2009 |
A newly discovered neurotoxin ADTIQ associated with hyperglycemia and Parkinson's disease.
Topics: alpha-Synuclein; Animals; Brain; Cell Death; Cell Line; Diabetes Mellitus, Experimental; Dopaminergic Neurons; Glucose; Humans; Hyperglycemia; Mice; Mice, Transgenic; Mutant Proteins; Neurotoxins; Parkinson Disease; Pyruvaldehyde; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines | 2015 |
Hsp31 Is a Stress Response Chaperone That Intervenes in the Protein Misfolding Process.
Topics: alpha-Synuclein; Amino Acid Sequence; Catalytic Domain; Heat-Shock Proteins; Humans; Lactic Acid; Lactoylglutathione Lyase; Molecular Sequence Data; Oxidative Stress; Prions; Protein Aggregates; Protein Folding; Protein Multimerization; Protein Structure, Quaternary; Pyruvaldehyde; Reactive Oxygen Species; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins | 2015 |
Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies.
Topics: Aging; alpha-Synuclein; Animals; Cell Differentiation; Cell Survival; Cells, Cultured; Disease Models, Animal; Drosophila; Enzyme Inhibitors; Female; Glycosylation; Hippocampus; Humans; Induced Pluripotent Stem Cells; Male; Mice; Mice, Transgenic; Neurodegenerative Diseases; Protein Aggregation, Pathological; Protein Processing, Post-Translational; Pyruvaldehyde; Rats; Yeasts | 2017 |
The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; alpha-Synuclein; Animals; Cell Line; Dopaminergic Neurons; Gene Expression Regulation, Enzymologic; Glycation End Products, Advanced; Humans; Hydrogen Peroxide; Mice; Oxidative Stress; Parkinson Disease; Pars Compacta; Protein Aggregates; Protein Deglycase DJ-1; Pyruvaldehyde; Substrate Specificity | 2019 |
Hsp27 reduces glycation-induced toxicity and aggregation of alpha-synuclein.
Topics: alpha-Synuclein; Brain Neoplasms; Glioma; Glycosylation; Heat-Shock Proteins; Humans; Molecular Chaperones; Protein Aggregates; Pyruvaldehyde; Tumor Cells, Cultured | 2020 |
Glycation modulates alpha-synuclein fibrillization kinetics: A sweet spot for inhibition.
Topics: alpha-Synuclein; Humans; Kinetics; Monosaccharides; Protein Aggregates; Protein Aggregation, Pathological; Protein Processing, Post-Translational; Pyruvaldehyde | 2022 |